90 related articles for article (PubMed ID: 7777242)
1. Severe cardiotoxicity of high-dose 5-fluorouracil in combination with folinic acid, cisplatin and methotrexate in a 14-year-old boy with nasopharyngeal carcinoma (Schmincke tumor).
Blütters-Sawatzki R; Grathwohl J; Mertens R; Lampert F
Oncology; 1995; 52(4):291-4. PubMed ID: 7777242
[TBL] [Abstract][Full Text] [Related]
2. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
Schwarz LR
Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406
[No Abstract] [Full Text] [Related]
3. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
O'Connell MJ; Klaassen DJ; Everson LK; Cullinan S; Wieand HS
NCI Monogr; 1987; (5):185-8. PubMed ID: 3501540
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer.
Schöber C; Papageorgiou E; Harstrick A; Bokemeyer C; Mügge A; Stahl M; Wilke H; Poliwoda H; Hiddemann W; Köhne-Wömpner CH
Cancer; 1993 Oct; 72(7):2242-7. PubMed ID: 8374883
[TBL] [Abstract][Full Text] [Related]
5. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
Rodriguez-Galindo C; Wofford M; Castleberry RP; Swanson GP; London WB; Fontanesi J; Pappo AS; Douglass EC
Cancer; 2005 Feb; 103(4):850-7. PubMed ID: 15641027
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
[TBL] [Abstract][Full Text] [Related]
7. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Chua DT; Sham JS; Au GK
Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
[TBL] [Abstract][Full Text] [Related]
8. Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate.
Menges M; Schmidt C; Lindemann W; Ridwelski K; Pueschel W; Jüngling B; Feifel G; Schilling M; Stallmach A; Zeitz M
J Cancer Res Clin Oncol; 2003 Jul; 129(7):423-9. PubMed ID: 12836016
[TBL] [Abstract][Full Text] [Related]
9. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carcinoma in childhood and adolescence: concept and preliminary results of the cooperative GPOH study NPC-91. Gesellschaft für Pädiatrische Onkologie und Hämatologie.
Mertens R; Granzen B; Lassay L; Gademann G; Hess CF; Heimann G
Cancer; 1997 Sep; 80(5):951-9. PubMed ID: 9307197
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
12. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma.
Celik I; Kars A; Ozyar E; Tekuzman G; Atahan L; Firat D
J Clin Oncol; 1996 Mar; 14(3):1043-4. PubMed ID: 8622011
[No Abstract] [Full Text] [Related]
13. Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma.
Hong RL; Ting LL; Ko JY; Hsu MM; Sheen TS; Lou PJ; Wang CC; Chung NN; Lui LT
J Clin Oncol; 2001 Dec; 19(23):4305-13. PubMed ID: 11731513
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
[TBL] [Abstract][Full Text] [Related]
15. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.
Droller MJ
J Urol; 2000 May; 163(5):1601. PubMed ID: 10798920
[No Abstract] [Full Text] [Related]
18. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK
J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil cardiotoxicity.
Lomeo AM; Avolio C; Iacobellis G; Manzione L
Eur J Gynaecol Oncol; 1990; 11(3):237-41. PubMed ID: 2170140
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
